Premier AI Trials QuantHealth is a global leader in AI-powered clinical trial simulation with a track record of simulating over 600 trials across 30 indications and partnering with 12 of the world's top 20 pharmaceutical companies, indicating strong credibility and a high-value target base for enterprise pharma and biotech clients.

High Accuracy Promise The platform reports up to 90% accuracy in predicting trial outcomes, presenting a compelling value proposition for reducing development risk, accelerating timelines, and improving go/no-go decision quality for drug development programs.

Rapid Growth Funding Recent $45M Series B funding led by Qumra Capital with strategic investors signals validate demand and financial momentum, enabling expansion in AI models, datasets, and therapeutic coverage—a signal to engage potential growth-stage partners and co-development opportunities.

Israel Expansion Plans to expand R&D capabilities, next-generation AI models, datasets, and therapeutic coverage in Israel create potential local partnerships, regional pilots, and access to specialized AI talent and clinical data resources for collaborations.

Multi-Channel Platform Existing tech stack and partnerships with major cloud, CRM, and collaboration tools suggest readiness for enterprise integrations and tailored deployment for large pharma customers, enabling cross-sell into analytics, data integration, and digital trial design workflows.